Popular NAD Supplement Nicotinamide Riboside Failed to Slow Early Parkinson's in a Year-Long Trial of 410 Patients
A 410-patient JAMA trial found that the NAD supplement nicotinamide riboside did not slow early Parkinson's. What patients and caregivers should know now.
Medical Daily ·